Skip to main content

Polypharmacy

0
Pipeline Programs
5
Companies
5
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Innovation Pharmaceuticals
2 programs
Electronic decision support for deprescribingN/A1 trial
MedReviewRxN/A1 trial
Active Trials
NCT04087109Withdrawn0Est. Jan 2022
NCT04762303Unknown1,000Est. Oct 2022
Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
1 program
Clinical decision supportN/A1 trial
Active Trials
NCT05656560Active Not Recruiting786Est. May 2027
Shield Therapeutics
Shield TherapeuticsMA - Wellesley
1 program
Deprescribing InterventionN/A1 trial
Active Trials
NCT04553107Completed419Est. Jun 2022
Martin Pharmaceuticals
1 program
Medication plan reviewN/A1 trial
Active Trials
NCT05526963Recruiting1,146Est. Dec 2025

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
Martin PharmaceuticalsMedication plan review
Angeles TherapeuticsClinical decision support
Innovation PharmaceuticalsMedReviewRx
Innovation PharmaceuticalsElectronic decision support for deprescribing
Shield TherapeuticsDeprescribing Intervention

Clinical Trials (5)

Total enrollment: 3,351 patients across 5 trials

NCT05526963Martin PharmaceuticalsMedication plan review

Reduction of Polypharmacy in Elderly People With Multiple Diseases

Start: May 2024Est. completion: Dec 20251,146 patients
N/ARecruiting
NCT05656560Angeles TherapeuticsClinical decision support

Reducing High-Risk Geriatric Polypharmacy Via EHR Nudges R01 Trial

Start: Jun 2023Est. completion: May 2027786 patients
N/AActive Not Recruiting
NCT04762303Innovation PharmaceuticalsMedReviewRx

Spread and Scale of a Polypharmacy App

Start: Aug 2021Est. completion: Oct 20221,000 patients
N/AUnknown
NCT04087109Innovation PharmaceuticalsElectronic decision support for deprescribing

MedSafer E-care: an Automated Deprescribing Solution (E-CARE Study)

Start: Jan 2021Est. completion: Jan 20220
N/AWithdrawn
NCT04553107Shield TherapeuticsDeprescribing Intervention

Reducing Costs by Deprescribing Medications

Start: Dec 2019Est. completion: Jun 2022419 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 3,351 patients
5 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.